title: Erythropoiesis-stimulating agents and quality of life: personal journeys of a cancer survivor, oncologist, and two cancer health services researchers.
authors: 1] Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA [2] Arnold School of Public Health, University of South Carolina, Columbia, SC, USA [3] Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA [4] WJB Dorn VA Medical Center, Columbia, SC, USA.
authors: C L
authors: CL
authors: Bennett
authors: Southern Network on Adverse Reactions (SONAR) Program, South Carolina College of Pharmacy, Columbia, SC, USA.
authors: J
authors: J
authors: Bian
mesh_terms: D000818:Animals; D001291:Attitude of Health Personnel; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008495:Medical Oncology; D009369:Neoplasms / Q000628:therapy*; D011788:Quality of Life; D012108:Research Personnel; D017741:Survivors
chemical_list: D006397:Hematinics; D004921:Erythropoietin